Gabriel Theron is not someone who is easily put off. So when his efforts to raise R500m and list on the JSE failed recently, he dismissed the setback as merely “disappointing”.

He tells the FM that it has not changed his goals for a company that has bet the house on cannabis. It’s the healing potential that excites Theron about the once notorious herb, which has undergone an image makeover from dagga, a pot-smoker drug, to a plant with “endless medicinal possibilities” and its more acceptable appellation: cannabis...

This article is free to read if you sign up or sign in.

If you have already registered or subscribed, please sign in to continue.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.